HomeLiterature Search
Popular searches
Risk-reducing mastectomy.

Edlich(Richard F),Winters(Kathryne L),Faulkn… J Long Term Eff Med Implants 2006-12-19

...BRCA2. Correct staging of breast cancer patients is critical. It permits an accurate diagnosis, as well as in many cases...

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic …

Farshid(Gelareh),Balleine(Rosemary L),Cummin… Am J Surg Pathol 2006-12-15

...BRCA2-associated breast cancer from kConFab families. After reviewing the literature, we agreed on a semiquantitative sc...

Prevalent mutations in prostate cancer.

Dong(Jin-Tang) J Cell Biochem 2006-04-13

...BRCA2, CHEK2 (RAD53), CYP17, CYP1B1, CYP3A4, GSTM1, GSTP1, GSTT1, PON1, SRD5A2, and VDR that have germline genetic varia...

Enhanced induction of prostatic dysplasia and carcinoma in Noble rat model by c…

Yuen(Mong-Ting),Leung(Lai-Kwok),Wang(Jun),Wo… Int J Oncol 2006-02-03

...BRCA2, PTEN, and Rap1) and tubulin-alpha are markedly decreased in dysplastic and neoplastic lesions. In addition, loss ...

Influence of selected lifestyle factors on breast and ovarian cancer risk in BR…

Gronwald(Jacek),Byrski(Tomasz),Huzarski(Toma… Breast Cancer Res Treat 2006-10-24

...BRCA2 mutation is as high as 80%, and the risk estimates for ovarian cancer range from 15 to 40%. Several environmental ...

Large genomic deletions inactivate the BRCA2 gene in breast cancer families.

Agata(S),Dalla Palma(M),Callegaro(M),Scaini(… J Med Genet 2006-07-24

BRCA1 and BRCA2 are the two major genes responsible for the breast and ovarian cancers that cluster in families with a g...

Molecular characterization and cancer risk associated with BRCA1 and BRCA2 spli…

Tesoriero(A A),Wong(E M),Jenkins(M A),Hopper… Hum Mutat 2006-06-13

...BRCA2 (BRCA1, c.IVS6-2delA, c.IVS9-2A>C, c.IVS4-1G>T, c.IVS20+1G>A and BRCA2, c.IVS17-1G>C, c.IVS20+1G>A, c.IVS7-1G>A) a...

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updat…

Gronwald(Jacek),Tung(Nadine),Foulkes(William… Int J Cancer 2006-04-28

...BRCA2 carriers has not been well evaluated. We studied 285 women with bilateral breast cancer and a BRCA1 or BRCA2 mutat...

Breast cancer and pregnancy.

Leslie(Kimberly K),Lange(Carol A) Obstet Gynecol Clin North Am 2006-01-31

...BRCA2 are also discussed.

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotyp…

Cass(Ilana),Holschneider(Christine),Datta(Na… Obstet Gynecol 2006-02-22

...BRCA2. Excluding 4 cases found at prophylactic surgery, the median age of diagnosis of BRCA mutation carriers was 57 yea...

Previous 384 385 386 387 388 389 390 391 392 Next Vol. 388 / of 636

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com